Zuga Matt
SEC CIK 1790214 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | CFO, Chief Business Off | 304.9K | — | $146.4K | 12 | 2021-07-06 | 2026-01-21 |
Most active insiders at ABOS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meisner Derek M | CLO, Corp Sec | — | $248.8K |
| 2 | OConnell Daniel Joseph | CEO, Dir | — | $163.2K |
| 3 | Porter Derrell | Dir | — | $75.2K |
| 4 | Zuga Matt | CFO, Chief Business Off | — | $49.6K |
| 5 | Barton Russell | COO | — | $30.0K |
| 6 | Siemers Eric | Chief Medical Off | — | $27.1K |
| 7 | Doherty James J. | Pres, CDO | — | $15.2K |
| 8 | Fountain Nathan B | Dir | — | $14.3K |
| 9 | Schacterle Amy | Chief Regulatory Off | — | $2,172 |
| 10 | Stoppel Laura | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-23 | 2026-01-21+ | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | S - Sale | $1.83 | -4,160 | 304.9K | -1% | -$7,614 |
| D | 2026-01-21 | 2026-01-16 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | A - Grant | $0.00 | +99.1K | 309.1K | +47% | $0 |
| 2026-01-12 | 2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | S - Sale | $1.82 | -6,888 | 210.0K | -3% | -$12.5K | |
| M | 2026-01-07 | 2026-01-05+ | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | S - Sale | $1.98 | -14.9K | 222.6K | -6% | -$29.5K |
| M | 2025-01-23 | 2025-01-21+ | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | S - Sale | $1.70 | -33.3K | 231.7K | -13% | -$56.7K |
| D | 2025-01-07 | 2025-01-03 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | S - Sale | $1.84 | -13.2K | 198.2K | -6% | -$24.4K |
| D | 2025-01-07 | 2025-01-06 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | A - Grant | $0.00 | +66.8K | 265.0K | +34% | $0 |
| 2024-01-19 | 2024-01-18 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | S - Sale | $3.71 | -4,242 | 211.4K | -2% | -$15.7K | |
| D | 2024-01-04 | 2024-01-02 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | A - Grant | $0.00 | +106.0K | 215.7K | +97% | $0 |
| D | 2023-01-18 | 2023-01-17 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | A - Grant | $0.00 | +33.5K | 109.7K | +44% | $0 |
| D | 2023-01-03 | 2022-12-29 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Off | M - OptEx | $1.19 | +50.0K | 76.2K | +191% | +$59.5K |
| D | 2021-07-08 | 2021-07-06 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO | C - Cnv Deriv | — | +26.2K | 26.2K | New | — |
Purchase Sale Sale after option exercise All abbreviations